Transcript Slide 1
Round 7 Overview of timelines and Responding to Malaria RBM Meeting - 15 January 2007 2007 – Round 7 Timeline February 22 – 23 Portfolio Committee Meeting. Agenda includes Review of Round 7 Proposal Form and Guidelines March 1 Launch Call for Proposals Round 7 July 4 Deadline for submission Round 7 August 26 NEW Round 7 TRP Member compulsory induction on Global Fund principles Aug - Sept 27 Aug – 7 Sept TRP Meeting to evaluate Round 7 proposals Geneva November 14 - 16 Sixteenth Board Meeting (Decision on Round 7) Kunming China Geneva NB. Applicants 4 months (increase from R6) to complete proposal forms IM/111006/7 Re-Cap - Round 6 Initiatives by Global Fund (1) 1. Participation in Stakeholder Organized information meetings -------------------------------------------------------Purpose • GF explanation of our forms & processes • Review of "weaknesses" from TRP Round 5 • Discussion on eligibility and CCM guidelines Beneficiaries • Largely EMRO, SEARO and some African nations • Statistically, fewer malaria managers or experts involved Global Fund position – not appropriate for countries to use funds from existing grants to attend such meetings and so other partner support is very much needed & appreciated Re-Cap - Round 6 Initiatives by Global Fund (2) 2. Very detailed "Frequently Asked Questions" Released at same time as Round 6 Call (R5 - too late/not detailed) All 6 UN languages + updated regularly over 3 months drafting time Benefits: Provides links to Technical Partner info (e.g., drug regimens) For first time - linkages also to implementation/programmatic info (* example provided on following slide) -------------------------------------------------------------------------------------------------3. After closing date - informal 'Questionnaire' sent to all applicants - Seeking input on country experiences with the R6 forms and "tools" 30% of respondents indicated M&E Toolkit was the most useful tool Query Whether additional or updated "indicator descriptions" should be prepared and introduced into the multi-agency M+E Toolkit for R7? Example of Round 6 "FAQ" approach for non-technical issues Question 72 (FAQ, version 4, 4 July 2006) Q: Are there any tools available to help applicants identify indicators for malaria in pregnancy (MIP) and incorporate these indicators into ANC registers and maternal health cards for monitoring and evaluation purposes and the strengthening of health information systems at country level? A: Consider making use of the MIP Monitoring and Evaluation Guide which will be available within the MIP Tool KIT, http://rbm.who.int/mpwg.html#miptk (mainly for Sub-Saharan African countries). Applicability to Round 7? Technical FAQs – require WHO "sign-off" as key Technical Partner Implementation Focused FAQs – require common voice in relevant community Such input – sent to: [email protected] by 9 Feb 2007 Looking forward to R7 Forms Largely – Proposal Form will be as in Round 6 i.e: - HSS will, again, be "within the diseases" CCM sections will remain Focus on outcome and impact linked to harmonized, sustainable planning + Some proactive steps to help applicants, including: Questions themselves – less complex and shorter sentences "Repetition" will be removed where found Confusing budget tables removed SE/111006/3 Top Ten Indicators - Outcome For routine Global Fund reporting 1. People treated with anti-retroviral combination therapy (ARV) HIV 2. New smear-positive TB cases detected (successful treatment, multi-drug-resistant TB) TB 3. ITNs distributed (LLIN and/or re-treated) Malaria 4. People receiving anti-malarial treatment Malaria 5. People counseled and tested for HIV HIV 6. HIV+ pregnant women receiving a complete course of PMTCT HIV 7. Condoms distributed HIV 8. People benefiting from community-based programs HIV/TB/Malaria 9. People treated for infections associated with HIV HIV/TB 10. Service deliverers trained HIV/TB/Malaria GP/111006/5 Looking at Round 6 Malaria Outcomes • Information collected through R6 TRP Review Forms • Categories used for purposes of analysis: – The Aidspan Guide to R6 Applications to the GF ** (www.aidspan.org) Chapter 3 Identifies: Strengths identified by the TRP most often Weaknesses identified by the TRP most often **(Not officially endorsed by Global Fund and also please see the Aidspan disclaimer on non-formal connection with the Global Fund) This analysis concerns Rd 3 – 5, but the same categories have been used to allow for comparison TRP Outcomes – Round 6 Take a few moments to review Global Fund supplied table If prioritizing resources is important… Then for Malaria there are a number of low success countries: Burkina Faso, Burundi Comoros, DRC, Dominican Republic, Ecuador India, Kenya Liberia, Madagascar, Yemen, Zambia etc Round 6 Appeal Outcome Mid Feb 07 (7 malaria appeals) TRP Membership Selection Timelines • TRP Replenishment typically occurs each 2 years • Report presented in April 06 for most recent • Next broad-based renewal will occur 2008 - Will benefit from Global Fund 5 year evaluation Interim changes also likely as a result of Nov 06 Board decisions ("RCC" implications are important) • Round 6 = 5 malaria experts (increase on R5) • John Chimumbwa is the only expert departing from 2006 and will be replaced through the TRP's own processes IM/111006/4 Global Fund Contribution to International Financing, 2005 • HIV/AIDS: 21% of all international funding commitments, i.e. US$ 1000 million • Malaria: 64% of all international funding commitments, i.e. US$ 308 million • TB: 67% of all international funding, i.e. US$ 133 million SE/111006/3